About Cypress Bioscience
Cypress Bioscience is a company based in San Diego (United States) founded in 1981 was acquired by Royalty Pharma in December 2010. Cypress Bioscience operates in a competitive market with competitors including Jazz Pharmaceuticals, Lundbeck, Sana Biotechnology, PureTech Health and AskBio, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cypress Bioscience, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Royalty Pharma
& 1 more
-
Employee Count
Not available
-
Acquired by
Royalty Pharma
(Dec 15, 2010)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cypress Bioscience
Detailed funding history for Cypress Bioscience
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Cypress Bioscience
Cypress Bioscience has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Royalty Pharma and TD Securities.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in marketed and late-stage biopharmaceutical companies.
|
Locked | Locked | Locked | |
|
Corporate finance advisory, mergers, acquisitions, and investment services are provided.
|
Locked | Locked | Locked |
Investor details for Cypress Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cypress Bioscience
Investment portfolio details for Cypress Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cypress Bioscience
Detailed financials for Cypress Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cypress Bioscience Comparisons
Peer comparison for Cypress Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cypress Bioscience
Cypress Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Lundbeck, Sana Biotechnology, PureTech Health and AskBio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Drugs for CNS disorders are developed and advanced.
|
|
| Locked | Locked | Locked |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
|
| Locked | Locked | Locked |
Gene and protein therapies are developed for treating various diseases.
|
|
| Locked | Locked | Locked |
Developer of therapeutic solutions for the treatment of diabetes
|
Detailed competitors of Cypress Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cypress Bioscience
Complete news archive for Cypress Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cypress Bioscience
Cypress Bioscience was founded in 1981.
Cypress Bioscience is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Cypress discovers and develops drugs for patients suffering from a variety of disorders of the central nervous system. The company FDA approved products includes Prosorba, a medical device for rheumatoid arthritis; and Savella (milnacipran HCl) for fibromyalgia. Its drug pipeline includes CYP-1020 for cognitive impairment in schizophrenia, Staccato nicotine for smoking cessation and intranasal carbetocin for autism. In Dec 2010, the company was acquired by the hedge fund Ramius and drug company Royalty Pharma.
Cypress Bioscience's top competitors include Jazz Pharmaceuticals, PTC Therapeutics and Neurocrine.
Cypress Bioscience has 2 investors. Key investors include Royalty Pharma, and TD Securities.